Table 3 Clinical and functional characteristics of IDC Cohort
From: A negative screen for mutations in calstabin 1 and 2 genes in patients with dilated cardiomyopathy
| IDC Cohort | |
|---|---|
| Clinical | |
| Biochemical | |
| Hemoglobin (mg/dL) | 12.7 ± 1.97 |
| Total Cholesterol (mg/dL) | 185 ± 55 |
| Triglycerides (mg/dL) | 106 ± 56 |
| HDL (mg/dL) | 45.7 ± 17.3 |
| LDL (mg/dL) | 116 ± 44 |
| Creatinin (mg/dL) | 1.2 ± 0.3 |
| BMI (kg/m2) | 25.08 ± 4.65 |
| Heart Rate (pm) | 76.35 ± 13.57 |
| Diastolic Blood Pressure (mmHg) | 67.41 ± 14.56 |
| Systolic Blood Pressure (mmHg) | 104.44 ± 18.9 |
| Echocardiographic | |
| Left Atrium Diameter, mm | 47.52 ± 8.48 |
| Aortic Diameter, mm | 32.57 ± 4.26 |
| Right Ventricle Diameter, mm | 27.19 ± 6.14 |
| Left Ventricle | |
| Intraventricular Septum, mm | 8.39 ± 1.48 |
| Posterior Wall Thickness, mm | 8.31 ± 1.21 |
| Diastolic Diameter, mm | 73.55 ± 10.06 |
| Systolic Diameter, mm | 64.01 ± 9.58 |
| Ejection Fraction, (%) | 35.08 ± 8.9 |
| Mass, g | 268.74 ± 77 |